Ligand profile
ZINC2522618
Virtual-screening candidate from ZINC.
Bound to: VK055_0344 — 4-hydroxy-2-oxovalerate aldolase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2522618- UniProt (similar protein)
Q8F3Q1- Tanimoto
- 0.515
- Target protein
- VK055_0344
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 135.5
- −1 ≤ LogP ≤ 5 -1.20
- MW ≤ 500 Da 245.3
- LogP ≤ 5 -1.20
- H-bond donors ≤ 5 4
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 135.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)OCC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)O
InChI=1S/C10H19N3O4/c1-3-5(2)8(12)9(15)13-6(10(16)17)4-7(11)14/h5-6,8H,3-4,12H2,1-2H3,(H2,11,14)(H,13,15)(H,16,17)/t5-,6-,8-/m0/s1InChI=1S/C10H19N3O4/c1-3-5(2)8(12)9(15)13-6(10(16)17)4-7(11)14/h5-6,8H,3-4,12H2,1-2H3,(H2,11,14)(H,13,15)(H,16,17)/t5-,6-,8-/m0/s1
HZYHBDVRCBDJJV-HAFWLYHUSA-NHZYHBDVRCBDJJV-HAFWLYHUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- ILE
- Homolog
- Q8F3Q1
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2522618 →
- ZINC ZINC20 ZINC2522618 →
- UniProt UniProt Q8F3Q1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2522618”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0344.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ZINC 45
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).